Insmed (INSM) Misses Q3 EPS by 7c ; Offers Guidance
Tweet
Share
E-mailGet Alerts INSM Hot Sheet
Price: $95.80 -2.69%
Revenue Growth %: +264.2%
Financial Fact:
Total operating expenses: 37.15M
Today's EPS Names:
DTGI, CRMT, MAYS, More
Revenue Growth %: +264.2%
Financial Fact:
Total operating expenses: 37.15M
Today's EPS Names:
DTGI, CRMT, MAYS, More
Join SI Premium – FREE
Insmed (NASDAQ: INSM) reported Q3 EPS of ($1.27), $0.07 worse than the analyst estimate of ($1.20). Revenue for the quarter came in at $93.42 million versus the consensus estimate of $93.35 million.
GUIDANCE:
Insmed sees FY2024 revenue of $340-360 million, versus the consensus of $357.1 million.
For earnings history and earnings-related data on Insmed (INSM) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Kalshi in early talks for IPO - The Information
- Kroger (KR) Reports In-Line Q1 EPS, Beats on Revenue; Offers FY27 EPS Guidance
- Air France-KLM (AF:FP) (AFLYY) PT Raised to EUR13.50 at UBS
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
